Real-world implementation of continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson’s disease: first clinical experience from the Middle East

Shivam Om Mittal, Kiran Waqar, Emma De Freitas, Yasmin Abdelmajid, Arshiya Anjum, Leanne Brown, Moncy Thomas

Therapeutic Advances in Neurological Disorders

Published online on July 15, 2026

Abstract

Therapeutic Advances in Neurological Disorders, Volume 19, January-December 2026.
Background:Continuous subcutaneous foslevodopa/foscarbidopa (FLD/FCD) is the first 24-h levodopa-based subcutaneous infusion therapy for advanced Parkinson’s disease (PD). Real-world data from the Middle East region are absent.Objectives:To report the ...